Divis Laboratories Share Price

ABOUT Divis Laboratories

• Industry Biotechnology & Drugs
• ISIN INE361B01024
• BSE Code 532488
• NSE Code DIVISLAB

Divi's Laboratories Limited is an India-based company, which is engaged in pharmaceutical ingredients (APIs), intermediates and nutraceutical ingredients with predominance in exports. The Company’s products include Bupropion HCl, Capecitabine, Carbidopa, Diltiazem HCl, Dextromethorphan Base, Dextromethorphan HBr, Gabapentin, Iopamidol, Iohexol, Irbesartan, Lacosamide, Levetiracetam, Levodopa, Losartan, Nabumetone, Naproxen, Naproxen Sodium, Olmesartan Medoxomil, Pregabalin, Ticagrelor, Triprolidine HCl, Valacyclovir HCl, Valsartan, Venlafaxine HCl, Vigabatrin, and others. The Company is also engaged in custom synthesis (contract manufacturing services) of APIs and Intermediates for global innovator companies with a portfolio of products across diverse therapeutic areas. The Company’s subsidiaries include Divis Laboratories (USA) Inc. and Divi’s Laboratories Europe AG.

MANAGEMENT

• Kiran Divi Chief Executive Officer, Whole-time Director
• L. Kishore Babu Chief Financial Officer
• Venkatesa Pasumarthy Chief Financial Officer
• Manoranjan Jasti Chief Information Officer
• Meka Satish Choudhury Compliance Officer, Company Secretary
• Murali Divi Managing Director, Executive Director
• Nilima Divi Whole-Time Director - (Commercial)
• Nimmagadda Ramana Executive Director
• Sureddy Rao Whole-Time Director - (Manufacturing)